Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

FEED

ENvue Medical Inc

Dec 19 • 04:00PM ET

3.00

-0.34 -10.18 %

Healthcare • Medical Devices • USA • NASD

Peers: INVA IRIX STXS OFIX PAVM LUNA MLSS ATEC ASMB MVIS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-96.17	Insider Own	0.76%	Shs Outstand	1.09M	Perf Week	-26.83%
Market Cap	3.26M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.08M	Perf Month	-23.86%
Enterprise Value	-2.55M	PEG	-	EPS next Q	-	Inst Own	0.15%	Short Float	2.12%	Perf Quarter	-59.51%
Income	-5.21M	P/S	1.21	EPS this Y	-	Inst Trans	-	Short Ratio	0.24	Perf Half Y	-66.85%
Sales	2.69M	P/B	0.07	EPS next Y	-	ROA	-11.79%	Short Interest	0.02M	Perf YTD	-95.38%
Book/sh	42.00	P/C	0.47	EPS next 5Y	-	ROE	-15.71%	52W High	162.50 -98.15%	Perf Year	-95.75%
Cash/sh	6.42	P/FCF	-	EPS past 3/5Y	52.09% 40.47%	ROIC	-12.26%	52W Low	3.27 -8.26%	Perf 3Y	-99.59%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.70% 37.00%	Gross Margin	30.02%	Volatility	13.45% 12.38%	Perf 5Y	-99.87%
Dividend TTM	-	EV/Sales	-0.95	EPS Y/Y TTM	29.19%	Oper. Margin	-351.77%	ATR (14)	0.46	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.67	Sales Y/Y TTM	-18.41%	Profit Margin	-193.89%	RSI (14)	31.35	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.86	EPS Q/Q	97.68%	SMA20	-24.98%	Beta	2.07	Target Price	10.50
Payout	-	Debt/Eq	0.03	Sales Q/Q	92.02%	SMA50	-37.02%	Rel Volume	0.30	Prev Close	3.34
Employees	31	LT Debt/Eq	0.00	Earnings	-	SMA200	-81.41%	Avg Volume	93.73K	Price	3.00
IPO	May 28, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	28,419	Change	-10.18%

Dec-15-25 09:00AM	ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman (Business Wire) -5.61%
Nov-19-25 08:00AM	NanoVibronix Issues Letter to Shareholders (Business Wire) -8.80%
Sep-18-25 08:00AM	NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities (Business Wire)
Sep-16-25 03:57PM	NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (Business Wire) -28.50%
Sep-15-25 08:00AM	NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio (Business Wire) +64.87%
08:00AM	Loading…
Sep-04-25 08:00AM	NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology (Business Wire)
Aug-08-25 09:00AM	NanoVibronix Announces Reverse Stock Split (Business Wire)
Jul-18-25 09:00AM	NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock (Business Wire)
Jun-26-25 08:00AM	NanoVibronix Announces ENvue Drive First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation (Business Wire)
Jun-24-25 08:00AM	NanoVibronixs ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue Navigation Systems for Enteral Feeding Tube Placement (Business Wire)
Jun-11-25 08:00AM	ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System (Business Wire) +47.51%
Jun-04-25 08:38AM	NanoVibronix Announces CEO Transition (Business Wire)
May-28-25 04:22PM	NanoVibronix Responds to False Post (Business Wire) -27.49% +46.10%
08:00AM	Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures (Business Wire)
May-16-25 04:30PM	NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants (Business Wire) -13.99% +5.69%
09:00AM	Loading…
May-15-25 09:00AM	NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants (Business Wire) -62.57%
May-12-25 08:50AM	NanoVibronix Announces Results from UroShield Case Series (Business Wire)
Apr-11-25 08:00AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Apr-01-25 08:00AM	NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia (Business Wire) -10.56%
Mar-21-25 06:36AM	Why Nanovibronix Inc. (NAOV) Surged On Thursday? (InsiderMonkey)
Mar-14-25 08:00AM	Successful Independent Study of the NanoVibronix UroShield Device Published in the Australian and New Zealand Continence Journal (Business Wire) -16.41%
Mar-12-25 08:00AM	NanoVibronix Announces Reverse Stock Split (Business Wire) -32.15%
Feb-14-25 09:43AM	NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. (Business Wire) -5.58%
Jan-07-25 08:00AM	NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes (Business Wire) -18.30%
05:53AM	Transforming catheter care: NanoVibronix completes successful UroShield US trial (Medical Device Network)
Jan-06-25 11:16AM	NanoVibronix achieves goals of US trial pilot phase with UroShield (Medical Device Network) +16.47%
08:00AM	NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan (Business Wire)
Dec-11-24 08:00AM	NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement (Business Wire) -14.29%
Nov-12-24 08:00AM	NanoVibronix Provides Business Update (Business Wire) +5.97%
Oct-09-24 08:30AM	NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany (Business Wire)
08:30AM	Loading…
Sep-23-24 08:30AM	NanoVibronix Signs Letter of Intent with Potential New Distributor (Business Wire)
Aug-21-24 08:30AM	NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders (Business Wire)
May-22-24 08:30AM	NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan (Business Wire)
May-16-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
May-15-24 11:53PM	NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024 (InvestorPlace)
May-14-24 12:55PM	NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield (MT Newswires)
08:30AM	NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield (Business Wire)
May-03-24 07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-01-24 08:00AM	NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs FSS Contract Award (Business Wire) -6.12%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-24-24 01:00PM	NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 (ACCESSWIRE)
Apr-10-24 07:52AM	NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 (InvestorPlace) -9.15%
Apr-09-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
Mar-28-24 08:30AM	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield (Business Wire)
Dec-06-23 09:00AM	NanoVibronix Featured in Your Bladder Health Magazine (Business Wire)
Dec-04-23 09:00AM	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity (Business Wire)
Nov-28-23 09:00AM	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan (Business Wire) -13.87%
Nov-21-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire) +9.16%
Nov-14-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Nov-07-23 08:30AM	NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1 (Business Wire)
Sep-27-23 08:00AM	NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire)
Sep-06-23 08:30AM	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting (Business Wire) -8.48%
Aug-30-23 02:29PM	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules (Business Wire) +67.59%
12:07PM	Why Is NanoVibronix Stock Trading Higher Today? (Benzinga)
08:30AM	NanoVibronix Cites Positive Results from Independent Testing of UroShield (Business Wire)
Aug-29-23 04:05PM	NanoVibronix Responds to CMS Determination for PainShield (Business Wire)
Aug-28-23 08:30AM	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire) -14.04%
Aug-23-23 08:45AM	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus (Business Wire) -5.62%
Jun-14-23 08:30AM	NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard (Business Wire)
May-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Apr-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Mar-28-23 08:30AM	NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS) (Business Wire)
Mar-21-23 08:30AM	NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra (Business Wire) +8.29%
Mar-14-23 09:15AM	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury (Business Wire)
Mar-03-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Feb-22-23 08:30AM	NanoVibronix to Launch Rental Program for PainShield and UroShield (Business Wire) +5.08%
Feb-08-23 12:00PM	NanoVibronix Announces Reverse Stock Split (Business Wire) -15.38%
Jan-18-23 08:30AM	NanoVibronix Provides Update on Expanding Access to PainShield (Business Wire) -7.57%
Dec-15-22 04:05PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire)
Dec-13-22 08:30AM	NanoVibronix Announces Partnership with Peak Medical, Ltd. (Business Wire)
Dec-09-22 06:11AM	Shareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation Acceptable (Simply Wall St.)
Dec-01-22 02:06PM	NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Nov-29-22 08:07AM	NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -21.00%
Nov-28-22 03:18PM	NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus (Business Wire) +144.27%
Nov-17-22 06:23AM	NanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021) (Simply Wall St.)
Nov-16-22 10:15AM	Interim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patients (Benzinga)
08:30AM	NanoVibronix Announces Interim Results of Clinical Study for UroShield (Business Wire)
Nov-15-22 08:33AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Oct-19-22 08:30AM	NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement (Business Wire)
Sep-23-22 08:30AM	NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract (Business Wire) +25.17%
Sep-14-22 04:05PM	NanoVibronix Sets Date for Annual Shareholder Meeting (Business Wire)
09:25AM	NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock (Business Wire)
Sep-02-22 04:30PM	NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing (Business Wire) -14.88%
Aug-18-22 11:30AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Jul-25-22 08:30AM	Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely? (Simply Wall St.) -5.15%
Jul-12-22 08:30AM	NanoVibronix Announces Webinar Series to Promote UroShield (Business Wire)
Jun-29-22 08:30AM	NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability (Business Wire)
May-17-22 08:30AM	NanoVibronix Reports First Quarter 2022 Financial Results (Business Wire) +5.16%
May-04-22 08:30AM	NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS (Business Wire) +5.39%
Apr-25-22 08:30AM	NanoVibronix Adds Additional Product to Federal Supply Schedule (Business Wire) +7.40%
Apr-05-22 08:30AM	NanoVibronix Advances Efforts to Achieve NHS Approval (Business Wire) -7.63%
Mar-30-22 11:16AM	Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices (Benzinga) +22.64%
08:30AM	NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices (Business Wire)
Feb-14-22 01:45PM	Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) -5.86%
Feb-07-22 08:30AM	NanoVibronix Added an Additional National Payer Network in Workers Compensation Market (Business Wire)
Jan-31-22 04:15PM	AM Best Upgrades Ratings of CNO Financial Group to A (Excellent) (PR Newswire)
Jan-24-22 08:30AM	NanoVibronix Extends Reach of UroShield and PainShield through MTSGs International Network (Business Wire)
Jan-19-22 08:30AM	NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology (Business Wire)
Jan-13-22 08:30AM	NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors (Business Wire)
Jan-07-22 01:02PM	NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FEED

ENvue Medical Inc

Upgrade your FINVIZ experience